Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

TYK MEDICINES-B

6.665
-0.305-4.38%
Volume:4.46M
Turnover:30.31M
Market Cap:2.53B
PE:-7.14
High:7.105
Open:6.775
Low:6.660
Close:6.970
52wk High:22.560
52wk Low:5.350
Shares:380.07M
HK Float Shares:375.46M
Volume Ratio:1.03
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.933
ROE:-70.66%
ROA:-28.19%
PB:8.32
PE(LYR):-7.14
PS:20292.82

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
TYK MEDICINES-B
Exchange:
SEHK
Establishment Date:
2017
Employees:
- -
Office Location:
Tower A, Changxing World Trade Building,Room 1403-2, Floor 14,No. 1278 Mingzhu Road,Changxing Economic Development Zone,Huzhou,Zhejiang Province,China
Website:
- -
Zip Code:
- -
Phone:
86 21 6167 6766
Fax:
- -
Introduction:
TYK Medicines Inc is a China-based company mainly engaged in developing and commercializing pharmaceutical products. The Company is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.

Directors

Name
Position
WU Yu Sheng
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee,科学委员会主席
LI Jun
Director,科学委员会委员
GU Hong
Director,Member of the Audit Committee
HE Chao
Director
ZHU Xiang Yang
Director
LENG Yu Ting
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee
XU Wen Qing
Independent Director,科学委员会委员
CHEN Xiu Hua
Independent Director
JIANG Xiao Lin
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Chairman of the Audit Committee

Shareholders

Name
Position
WU Yu Sheng
General Manager
HUANG Yong Yi
Corporate Secretary
NIU Cheng Shan
Other Senior Executives
LIANG A Peng
Other Senior Executives
CHEN Shao Qing
Other Senior Executives
CHEN Xiu Gui
Other Senior Executives